No association between N-acetyltransferase 2 (NAT2) and risk of diffuse type of gastric cancer

被引：2
|
作者：
Hosseini, Hedayatollah [1 ]
Dovranehgard, Fatemeh [2 ]
Arveysi, Sorya [2 ]
Galehdari, Hamid [3 ]
Masjedizadeh, Abdolrahim [1 ]
Shanaki, Mehrnoosh [1 ]
机构：
[1] Jondi Shapur Univ Med Sceince, Dept Biochem, Ahvaz, Iran
[2] Razi Univ, Dept Biol, Kermanshah, Iran
[3] Shahid Chamran Univ, Dept Genet, Ahvaz, Iran
来源：
TOXICOLOGY LETTERS | 2009年 / 189卷
关键词：
D O I：
10.1016/j.toxlet.2009.06.729
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [1] The association of polymorphic N-acetyltransferase (NAT2) with breast cancer risk
    Ambrosone, CB
    Freudenheim, JL
    Marshall, JR
    Graham, S
    Vena, JE
    Brasure, JR
    Michalek, AM
    Laughlin, R
    Nemoto, T
    Shields, PG
    CANCER PREVENTION: FROM THE LABORATORY TO THE CLINIC: IMPLICATIONS OF GENETIC, MOLECULAR, AND PREVENTIVE RESEARCH, 1995, 768 : 250 - 252
  • [2] N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk
    Bouchardy, C
    Mitrunen, K
    Wikman, H
    Husgafvel-Pursiainen, K
    Dayer, P
    Benhamou, S
    Hirvonen, A
    PHARMACOGENETICS, 1998, 8 (04): : 291 - 298
  • [3] N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer
    Alberg, AJ
    Daudt, A
    Huang, HY
    Hoffman, SC
    Comstock, GW
    Helzlsouer, KJ
    Strickland, PT
    Bell, DA
    CANCER DETECTION AND PREVENTION, 2004, 28 (03): : 187 - 193
  • [4] Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis
    K. Skrętkowicz
    J. Skrętkowicz
    B. Gawrońska-Szklarz
    W. Górnik
    M. Rychlik-Sych
    A. Sysa-Jędrzejowska
    European Journal of Clinical Pharmacology, 2005, 60 : 773 - 778
  • [5] Lack of association between arylamine N-acetyltransferase 2 (NAT2) polymorphism and systemic sclerosis
    Skretkowicz, K
    Skretkowicz, J
    Gawronska-Szklarz, B
    Górnik, W
    Rychlik-Sych, M
    Sysa-Jedrzejowska, A
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 60 (11) : 773 - 778
  • [6] Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population
    Marta Vilčková
    Jana Jurečeková
    Dušan Dobrota
    Viera Habalová
    Lucia Klimčáková
    Iveta Waczulíková
    Peter Slezák
    Ján Kliment
    Monika Kmeťová Sivoňová
    Medical Oncology, 2014, 31
  • [7] Association between bone loss in periodontal disease and polymorphism of N-acetyltransferase (NAT2)
    Kocher, T
    Sawaf, H
    Fanghänel, J
    Timm, R
    Meisel, P
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2002, 29 (01) : 21 - 27
  • [8] Variation in N-acetyltransferase 2 (NAT2), smoking and risk of prostate cancer in the Slovak population
    Vilckova, Marta
    Jurecekova, Jana
    Dobrota, Dusan
    Habalova, Viera
    Klimcakova, Lucia
    Waczulikova, Iveta
    Slezak, Peter
    Kliment, Jan
    Sivonova, Monika Kmetova
    MEDICAL ONCOLOGY, 2014, 31 (06)
  • [9] Breast cancer risk, meat consumption and N-acetyltransferase (NAT2) genetic polymorphisms
    Ambrosone, CB
    Freudenheim, JL
    Sinha, R
    Graham, S
    Marshall, JR
    Vena, JE
    Laughlin, R
    Nemoto, T
    Shields, PG
    INTERNATIONAL JOURNAL OF CANCER, 1998, 75 (06) : 825 - 830
  • [10] N-acetyltransferase (Nat) 1 and 2 expression in Nat2 knockout mice
    Loehle, Jennifer A.
    Cornish, Valerie
    Wakefield, Larissa
    Doll, Mark A.
    Neale, Jason R.
    Zang, Yu
    Sim, Edith
    Hein, David W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2006, 319 (02): : 724 - 728
12345